LONDON, Dec 29 (Reuters) - Ask executives in the healthcare industry about the future market for weight-loss drugs and the analogies are telling: monthly GLP-1 medicine subscriptions like a streaming video membership; dose decisions managed on a smartphone app; access made as easy as buying a pair of Nikes. This is their vision of the consumerization of weight-loss as drugmakers Novo Nordisk and Eli Lilly prepare to launch pill versions alongside their blockbuster injectable treatments and incr

As seniors age, they might encounter diminished versatility or wellbeing related issues that make getting to and leaving vehicles seriously testing. Luckily,

After watching "The AI Doc," one thing is clear: AI could solve some of humanity's biggest problems or create entirely new ones — depending on how we handle it.